Edition:
United States

Threshold Pharmaceuticals Inc (THLD.O)

THLD.O on Consolidated Issue listed on NASDAQ Capital Market

1.18USD
28 Sep 2016
Change (% chg)

$0.04 (+3.51%)
Prev Close
$1.14
Open
$1.14
Day's High
$1.20
Day's Low
$1.05
Volume
2,342,658
Avg. Vol
2,758,407
52-wk High
$4.44
52-wk Low
$0.21

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.09 December 29 Sep 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 1 1 1 1
(3) HOLD 2 2 2 3
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.25 2.25 2.25 2.40

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 1 0.00 0.00 0.00 5.17
Quarter Ending Dec-16 1 0.00 0.00 0.00 5.38
Year Ending Dec-16 2 0.00 0.00 0.00 24.03
Year Ending Dec-17 2 0.00 0.00 0.00 59.28
Earnings (per share)
Quarter Ending Sep-16 3 -0.09 -0.08 -0.09 -0.13
Quarter Ending Dec-16 3 -0.08 -0.08 -0.08 -0.13
Year Ending Dec-16 3 -0.38 -0.37 -0.38 -0.48
Year Ending Dec-17 3 -0.32 -0.25 -0.36 -0.20

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-16 0.00 0.00 0.00 0.00
Quarter Ending Mar-16 12.00 0.00 12.00 100.00
Quarter Ending Dec-15 4.18 65.87 61.69 1,474.28
Quarter Ending Sep-15 3.69 3.68 0.01 0.26
Quarter Ending Jun-15 3.60 3.68 0.08 2.19
Earnings (per share)
Quarter Ending Jun-16 -0.10 -0.10 0.00 -0.00
Quarter Ending Mar-16 -0.01 -0.11 0.10 -1,541.79
Quarter Ending Dec-15 -0.12 0.86 0.98 -804.92
Quarter Ending Sep-15 -0.14 -0.09 0.05 -33.33
Quarter Ending Jun-15 -0.14 -0.12 0.02 -15.31

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 0.00 0.00 0.00 0.00 5.17
Quarter Ending Dec-16 0.00 0.00 0.00 0.00 5.38
Year Ending Dec-16 0.00 0.00 0.00 0.00 24.03
Year Ending Dec-17 0.00 0.00 0.00 0.00 59.28
Earnings (per share)
Quarter Ending Sep-16 -0.09 -0.09 -0.09 -0.10 -0.13
Quarter Ending Dec-16 -0.08 -0.08 -0.08 -0.10 -0.13
Year Ending Dec-16 -0.38 -0.38 -0.38 -0.41 -0.48
Year Ending Dec-17 -0.32 -0.32 -0.32 -0.42 -0.20

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0
Earnings
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$115.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.